1. Seizures associated with levofloxacin: case presentation and literature review

   • Alfredo Bellon
   • Gonzalo Perez-Garcia
   • Ranjit C. Chacko

   Review Article 26 August 2009 Pages: 959 - 962

2. Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?

   • Helenie Kefalakes
   • Theodoros J. Stylianides
   • George Kolios

   Review Article 27 August 2009 Pages: 963 - 970

3. Genetic polymorphisms of CYP2D6 oxidation in patients with systemic sclerosis

   • Jadwiga Skrętkowicz
   • Malgorzata Baranska
   • Mariola Rychlik-Sych

   Pharmacogenetics 15 May 2009 Pages: 971 - 976

4. Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria

   • Ann K. Miller
   • Nibedita Bandyopadhyay
   • Stephen A. Ward

   Pharmacokinetics and Disposition 11 June 2009 Pages: 977 - 987

   

5. Pharmacokinetics and dose requirements of factor VIII over the age range 3–74 years

   • Sven Björkman
   • Anna Folkesson
   • Siv Jönsson

   Pharmacokinetics and Disposition 26 June 2009 Pages: 989 - 998

   

6. Effect of ritonavir on the pharmacokinetics of the benzimidazoles albendazole and mebendazole: an interaction study in healthy volunteers

   • Natascia Corti
   • Antje Heck
   • Christiane Pauli-Magnus

   Pharmacokinetics and Disposition 27 June 2009 Pages: 999 - 1006

   

7. Interpretation of clinical guidelines for poisoned patients: positive and negative effects of standard phrases used in TOXBASE

   • W. S. Waring
   • S. H. McDonald
   • D. N. Bateman

   Pharmacoepidemiology and Prescription 11 June 2009 Pages: 1007 - 1012

8. Impact of better adherence to statin agents in the primary prevention of coronary artery disease

   • Sylvie Perreault
   • Alice Dragomir
   • Danielle Pilon

   Pharmacoepidemiology and Prescription 16 June 2009 Pages: 1013 - 1024

   

9. Reexamining transaminase elevation in Phase I clinical trials: the importance of baseline and change from baseline

   • Zhaohui Cai
   • Anastasia M. Christianson
   • Marianne Keisu

   Pharmacoepidemiology and Prescription 25 June 2009 Pages: 1025 - 1035

   

10. Improved quality in the hospital discharge summary reduces medication errors—LIMM: Landskrona Integrated Medicines Management

    • Anna Bergkvist
    • Patrik Midlöv
    • Tommy Eriksson

    Pharmacoepidemiology and Prescription 26 June 2009 Pages: 1037 - 1046

    

11. No impact of age on dose-adjusted pharmacokinetics of tacrolimus, mycophenolic acid and prednisolone 1 month after renal transplantation

    • Masatomo Miura
    • Shigeru Satoh
    • Tomonori Habuchi

    Pharmacoeconomics 03 September 2009 Pages: 1047 - 1053

12. Severely diminished response to vitamin K-treatment for self-inflicted warfarin intoxication in a patient genotyped as CYP2C9*3*3

    • Tobias Bäckström
    • Gunilla Barkman
    • Erik Eliasson

    Letter to the Editors 30 May 2009 Pages: 1055 - 1055

13. Capecitabine-induced stomatitis: a likely pathogenetic mechanism of oral lichenoid mucositis

    • Michele D. Mignogna
    • Giulio Fortuna
    • Stefania Leuci

    Letter to the Editors 12 June 2009 Pages: 1057 - 1059

    

14. Pitfalls in patient self-management of subcutaneous drug application: removal of rubber protection caps from ready-to-use syringes

    • Seraina Mengiardi
    • Beat Goepfert
    • Kurt E. Hersberger

    Letter to the Editors 18 June 2009 Pages: 1061 - 1062